Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Current Taxes (2019 - 2025)

Ptc Therapeutics (PTCT) has 7 years of Current Taxes data on record, last reported at $4.7 million in Q4 2025.

  • For Q4 2025, Current Taxes fell 0.51% year-over-year to $4.7 million; the TTM value through Dec 2025 reached $4.7 million, down 0.51%, while the annual FY2025 figure was $4.7 million, 0.51% down from the prior year.
  • Current Taxes reached $4.7 million in Q4 2025 per PTCT's latest filing, up from $2.9 million in the prior quarter.
  • Across five years, Current Taxes topped out at $64.6 million in Q1 2025 and bottomed at $618000.0 in Q2 2021.
  • Average Current Taxes over 5 years is $10.0 million, with a median of $4.7 million recorded in 2025.
  • Peak YoY movement for Current Taxes: tumbled 70.17% in 2021, then soared 3425.48% in 2025.
  • A 5-year view of Current Taxes shows it stood at $1.3 million in 2021, then skyrocketed by 266.12% to $4.7 million in 2022, then crashed by 40.11% to $2.8 million in 2023, then surged by 66.58% to $4.7 million in 2024, then fell by 0.51% to $4.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Taxes were $4.7 million in Q4 2025, $2.9 million in Q3 2025, and $39.9 million in Q2 2025.